Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-270.18%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.01Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information
Ticker
MRKRCompany Name
MARKER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMARKER THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MRKR - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -14.56M | -270.18% | $ 5.39M |
| 3/31/2025 | $ -12.73M | -223.57% | $ 5.7M |
| 12/31/2024 | $ -10.68M | -162.06% | $ 6.59M |
| 9/30/2024 | $ -9.69M | -179.64% | $ 5.4M |
| 6/30/2024 | $ -10.37M | -278.12% | $ 3.73M |
| 3/31/2024 | $ -6.63M | -199.65% | $ 3.32M |
| 12/31/2023 | $ -8.23M | -248.65% | $ 3.31M |
| 9/30/2023 | $ -8.33M | -91.85% | $ 9.06M |
| 6/30/2023 | $ -11.22M | -87.96% | $ 12.76M |
| 3/31/2023 | $ -21.17M | -165.6% | $ 12.78M |
Key Performance Insights, Last 5 Years
- MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -3615.85%.
- Over the past 5 years, MARKER THERAPEUTICS INC's average EBITDA % has been -1369.77%.
- The median EBITDA % for MARKER THERAPEUTICS INC during this period was -274.15%
- MARKER THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -87.96%.
- The lowest EBITDA % recorded by MARKER THERAPEUTICS INC in the same timeframe -6266.79%
MARKER THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for MARKER THERAPEUTICS INC is calculated as follows: EBITDA [ $ -24.59M ] / Revenues [ $ 679.98K ]
(=) EBITDA % [ -3615.85% ] MRKR - EBITDA Margin, Last 5 years
-6266.79%
Minimum
Mar 31, 2021
-87.96%
Maximum
Jun 30, 2023
-1369.77%
Average
-274.15%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |